Your browser doesn't support javascript.
loading
Analysis of pathological complete response rates with paclitaxel-based regimens in trimodality therapy for esophageal cancer.
Boggs, D H; Tarabolous, C; Morris, C G; Hanna, A; Burrows, W; Horiba, N; Suntharalingam, M.
Afiliação
  • Boggs DH; Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD, USA.
  • Tarabolous C; Department of Medical Oncology, University of Maryland Medical Center, Baltimore, MD, USA.
  • Morris CG; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Hanna A; University of Maryland Medical School, Baltimore, MD, USA.
  • Burrows W; Department of Thoracic Surgery, University of Maryland Medical Center, Baltimore, MD, USA.
  • Horiba N; Department of Medical Oncology, University of Maryland Medical Center, Baltimore, MD, USA.
  • Suntharalingam M; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Dis Esophagus ; 28(7): 619-25, 2015 Oct.
Article em En | MEDLINE | ID: mdl-24863682
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Paclitaxel / Terapia Combinada / Protocolos Antineoplásicos / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Paclitaxel / Terapia Combinada / Protocolos Antineoplásicos / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article